Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Microbot Medical Inc. - Common Stock (NQ: MBOT )

2.720 +0.580 (+27.09%)
Streaming Delayed Price Updated: 3:30 PM EST, Jan 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 61,758,326
Open 2.770
Bid (Size) 2.710 (23)
Ask (Size) 2.720 (6)
Prev. Close 2.140
Today's Range 2.370 - 3.380
52wk Range 0.8200 - 2.350
Shares Outstanding 16,932,341
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Microbot Medical (MBOT) Stock Is Up 22% Today
Microbot Medical shares are trading higher by 33% during Monday's session. The company is raising $7 million through stock sales and investment options. 
Via Benzinga
Microbot Medical Announces $7 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From Microbot Medical Inc.
Via GlobeNewswire

Performance

YTD
+138.58%
+138.58%
1 Month
+178.18%
+178.18%
3 Month
+195.63%
+195.63%
6 Month
+151.83%
+151.83%
1 Year
+99.99%
+99.99%

More News

Read More
US Stocks To Open Higher In Yet Another Truncated Week: Nvidia, Robotic Stocks In Focus Ahead Of CES 2025
Via Benzinga
Why Smart Share Global Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Advanced Robotics Are Reshaping Medicine
Via News Direct
Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®
From Microbot Medical Inc.
Via GlobeNewswire
Palm-Sized Innovation: How Microbot Medical Is Helping Redefine Surgical Robotics
Via News Direct
Exposures Product Safety
Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access
From Microbot Medical Inc.
Via GlobeNewswire
Microbot Medical® Announces FDA Submission for the Commercialization of the LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
Global Medical Service Robotics Market Project to Exceed $20 Billion in 2024 with Additional Growth Expected
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025
From Microbot Medical Inc.
Via GlobeNewswire
Global Medical Service Robotics Market Project to Exceed $20 Billion in 2024 with Additional Growth Expected
From FN Media Group LLC
Via GlobeNewswire
Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up
From Microbot Medical Inc.
Via GlobeNewswire
Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System
From Microbot Medical Inc.
Via GlobeNewswire
Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
MBOT Stock Earnings: Microbot Medical Meets EPS for Q2 2024
Via InvestorPlace
Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization
From Microbot Medical Inc.
Via GlobeNewswire
Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System
From Microbot Medical Inc.
Via GlobeNewswire
Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center
From Microbot Medical Inc.
Via GlobeNewswire
Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial
From Microbot Medical Inc.
Via GlobeNewswire
Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial
From Microbot Medical Inc.
Via GlobeNewswire
Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial
From Microbot Medical Inc.
Via GlobeNewswire
Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial
From Microbot Medical Inc.
Via GlobeNewswire
Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial
From Microbot Medical Inc.
Via GlobeNewswire
Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From Microbot Medical Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.